دورية
Durable immunity to EBV post rituximab and third party LMP–specific T cells: a Children’s Oncology Group study
| العنوان: | Durable immunity to EBV post rituximab and third party LMP–specific T cells: a Children’s Oncology Group study |
|---|---|
| المؤلفون: | Wistinghausen, Birte, Toner, Keri, Barkauskas, Donald A., Jerkins, Lauren P, Kinoshita, Hannah, Chansky, Pamela, Pezzella, Gloria, Saguilig, Lauren, Hayashi R, Robert J., Abhyankar, Harshal, Scull, Brooks, Karri, Vivekanudeep, Tanna, Jay, Hanley, Patrick, Hermiston, Michelle L., Allen, Carl E., Bollard, Catherine M. |
| المصدر: | Blood Advances; 20240101, Issue: Preprints |
| مستخلص: | •LMP-TC bank comprising 14 products with 11 distinct HLA restrictions was sufficient to match a diverse national pediatric population.•Durable LMP-TC responses were observed in ND pediatric patients with PTLD after incomplete response to rituximab. |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 24739529 24739537 |
|---|---|
| DOI: | 10.1182/bloodadvances.2023010832 |